Raadi | Blue Cross MN

Soo bandhiga 531 - 540 ee natiijooyinka 3563

2025 Changes in prescription drug eligibility for 90dayRx

Wax badan akhri

Bixiye

January 2025 Bulletin Summary

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2025

Bixiye

QP92-24 Process Update for Post-Acute Care Authorizations managed by eviCore Healthcare

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024

Bixiye

QP91-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective February 1, 2025

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024

Bixiye

QP90-24 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 1, 2025

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024

Bixiye

QP93-24 Blue Cross and Blue Shield of Minnesota Collaborating with Maven

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024

Bixiye

QP94-24 MHCP Pharmacy Benefit Exclusion for Darzalex Faspro®, Supprelin® LA and Visudyne®

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024

Bixiye

QP96-24 Prescription Drug Electronic Prior Authorization (ePA) Submission Process Update

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024

Bixiye

QP97-24 Commercial Pharmacy Benefit Exclusion for oxytocin, Pitocin® and Prepidil® Gel

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024

Bixiye

QP95-24 Commercial Pharmacy Benefit Exclusion for lanreotide, Ultomiris® and Visudyne®

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Des 23, 2024